The potential of medical apps to improve care and lower costs is enormous. But if developers don’t know how these apps will be regulated, they’re going to spend their time on other pursuits rather than gamble on what regulators might do in the future.
There are two trends in healthcare that should give hospital IT professionals pause: BYOD and the Internet of Things. The bring-your-own-device (BYOD) trend is certainly not new, but hospitals are still figuring out how to navigate the security concerns.
Currently, the FDA does not regulate consumer medical apps, so, like the supplement industry, it’s a buyer-beware situation. Without rigorous clinical trials, there is no way to know which, if any, of these apps will actually improve health outcomes. Since few of these apps have been tested in clinical trials, their efficacy and safety are largely unknown.
We've all been there. Following an injury, you or a family member gets an X-ray or MRI but when you follow up with a specialist a few weeks later, he or she can't access the study. In this age of rapid-fast information sharing, it's hard to understand why this still happens. Do we have the technology to solve the problem?
Can medical kiosks, email and patient portals solve the growing shortage of primary care physicians? Perhaps not, but these technologies can help ease the burden on caregivers and even improve patient satisfaction.
How close are we to achieving the model of patient-centered care, facilitated by a free flow of information, that was envisioned by the Institute of Medicine more than a decade ago? Closer than you think.
The Institute of Health Technology Transformation recently released a report which identified data analytics for population health management to be one of the critical capabilities for a successful accountable care organization (ACO). The use of the latest technology advances for large scale, big data analytics across structured and unstructured health data sets has increasingly made the difference for successful ACOs, enabling them to achieve these requirements while others have struggled.
The pharmaceutical industry on the whole has been cautious about its use of social media and mobile technology, but the pace is rapidly picking up. The opportunities are great and the time is right for pharmaceutical companies to establish and strengthen their social strategies as they await further guidance from the FDA.